Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Allaart

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Arthritis Care & Research|February 15, 2013
Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patientsL Heimans, M van den Broek, S le Cessie, et al.
Arthritis Care & Research|August 5, 2015
Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and HesitationI M Markusse, L Dirven, K H Han, et al.
Scandinavian Journal of Rheumatology|July 2, 2004
Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexateR Rau, S Simianer, P L C M van Riel, et al.
Annals of the Rheumatic Diseases|April 26, 2011
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt studyM van den Broek, N B Klarenbeek, L Dirven, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritisK Visser, K N Verpoort, H van Dongen, et al.
Annals of the Rheumatic Diseases|October 20, 2007
Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity scoreS M van der Kooij, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, et al.
Annals of the Rheumatic Diseases|November 24, 2011
The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt studyM van den Broek, L Dirven, N B Klarenbeek, et al.
RMD Open|November 16, 2016
Age affects joint space narrowing in patients with early active rheumatoid arthritisX M E Matthijssen, G Akdemir, I M Markusse, et al.
Clinical Rheumatology|September 30, 2016
Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remissionG Akdemir, I M Markusse, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|August 5, 2011
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritisN B Klarenbeek, R Koevoets, D M F M van der Heijde, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Arthritis Care & Research|February 15, 2013
Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patientsL Heimans, M van den Broek, S le Cessie, et al.
Arthritis Care & Research|August 5, 2015
Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and HesitationI M Markusse, L Dirven, K H Han, et al.
Scandinavian Journal of Rheumatology|July 2, 2004
Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexateR Rau, S Simianer, P L C M van Riel, et al.
Annals of the Rheumatic Diseases|April 26, 2011
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt studyM van den Broek, N B Klarenbeek, L Dirven, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritisK Visser, K N Verpoort, H van Dongen, et al.
Annals of the Rheumatic Diseases|October 20, 2007
Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity scoreS M van der Kooij, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, et al.
Annals of the Rheumatic Diseases|November 24, 2011
The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt studyM van den Broek, L Dirven, N B Klarenbeek, et al.
RMD Open|November 16, 2016
Age affects joint space narrowing in patients with early active rheumatoid arthritisX M E Matthijssen, G Akdemir, I M Markusse, et al.
Clinical Rheumatology|September 30, 2016
Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remissionG Akdemir, I M Markusse, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|August 5, 2011
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritisN B Klarenbeek, R Koevoets, D M F M van der Heijde, et al.
Pageof 9